MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/aogs.12590

Медицинская библиотека · Acta obstetricia et gynecologica Scandinavica · 2015

Diagnosis and treatment of severe hemolytic disease of the fetus and newborn: a 10-year nationwide retrospective study.

Sainio Susanna, Nupponen Irmeli, Kuosmanen Malla, Aitokallio-Tallberg Ansa, Ekholm Eeva, Halmesmäki Erja, Orden Maija-Riitta, Palo Pertti, Raudaskoski Tytti, Tekay Aydin, Tuimala Jarno, Uotila Jukka, Stefanovic Vedran

Оценочное исследованиеСтатьяПеревод в очереди

Аннотация

OBJECTIVE

Outcome after intrauterine transfusions due to severe hemolytic disease of the fetus and newborn.

DESIGN

Nationwide population-based retrospective cohort study.

SETTING

All women treated with intrauterine transfusions for hemolytic disease of the fetus and newborn in Finland in 2003-2012.

POPULATION: 339 intrauterine transfusions, performed in 104 pregnancies of 84 women.

METHODS

Information on antenatal screening of red cell antibodies and red cell units issued for intrauterine transfusion was obtained from the Finnish Red Cross Blood Service database, and obstetric and neonatal data from hospital records.

MAIN OUTCOME MEASURES: Procedure-related complications, perinatal mortality, neonatal morbidity.

RESULTS

Overall survival was 94.2% (95% confidence interval 89.7-98.7). There were four fetal and two neonatal deaths. Procedure-related fetal loss rate was 1.2% (95% confidence interval 0.04-2.4) per procedure and 3.8% (95% confidence interval 0.1-7.5) per pregnancy. Of the four procedure-related losses, three were due to technically difficult intrauterine transfusions causing infection and preterm birth. Of the live born infants, 19% (95% confidence interval 11.3-26.7) were born before 32 weeks' gestation. The incidence of severe neonatal morbidity (respiratory distress syndrome, severe cerebral injury, sepsis) was 22.2% (95% confidence interval 13.4-30.2). Poor outcome (death, severe neonatal morbidity) was negatively associated with gestational age at first transfusion (p = 0.001) and at birth (p = 0.00006). Follow-up of the infants was too incomplete to assess the neurodevelopmental outcome.

CONCLUSIONS

Although overall survival is comparable with previous studies, our concern is procedure-related infections and preterm births. Close collaboration between the university hospitals is needed to ensure timely treatment, operator skills and systematic follow-up of the children.

Для цитирования: Sainio Susanna, Nupponen Irmeli, Kuosmanen Malla, Aitokallio-Tallberg Ansa, Ekholm Eeva, Halmesmäki Erja, Orden Maija-Riitta, Palo Pertti, Raudaskoski Tytti, Tekay Aydin, Tuimala Jarno, Uotila Jukka, Stefanovic Vedran. Diagnosis and treatment of severe hemolytic disease of the fetus and newborn: a 10-year nationwide retrospective study.. Acta obstetricia et gynecologica Scandinavica. 2015. DOI: 10.1111/aogs.12590.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.